Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...
Beta-blocker therapy after myocardial infarction (MI) failed to lower the rate of all-cause death, MI, or heart failure in patients with a left ventricular ejection fraction (LVEF) of at least 50%, ...